©The Author(s) 2019.
World J Clin Cases. Feb 26, 2019; 7(4): 452-465
Published online Feb 26, 2019. doi: 10.12998/wjcc.v7.i4.452
Published online Feb 26, 2019. doi: 10.12998/wjcc.v7.i4.452
Table 1 Clinical characteristics
| 1.2 L PEG-ASC (n = 156) | PEG-ELS (n = 156) | Total (n = 312) | P value | |
| Age (mean, range) | 62.6 (19-89) | 63.5 (24-89) | 63.0 (19-89) | 0.21 |
| Sex (male, %) | 93 (59.6) | 84 (53.8) | 177 (56.7) | 0.30 |
| Constipation, n (%) | 39 (25.0) | 38 (24.4) | 77 (24.7) | 0.89 |
| Abdominal operation, n (%) | 58 (37.2) | 55 (35.3) | 113 (36.2) | 0.72 |
| Hypertension, n (%) | 36 (23.1) | 26 (16.7) | 62 (19.9) | 0.16 |
| Diabetes, n (%) | 12 (7.7) | 15 (9.6) | 27 (8.7) | 0.54 |
| Experience of colonoscopy, n (%) | 89 (57.0) | 87 (55.8) | 176 (56.4) | 0.81 |
| Indications for colonoscopy, n (%) | ||||
| Occult blood test-positive | 76 (48.7) | 70 (44.9) | 146 (46.8) | 0.50 |
| Surveillance | 30 (19.2) | 27 (17.3) | 57 (18.3) | 0.66 |
| Screening | 21 (13.5) | 22 (14.1) | 43 (13.8) | 0.87 |
| Blood in stool | 10 (6.4) | 13 (8.3) | 23 (7.4) | 0.52 |
| Abdominal pain | 5 (3.2) | 6 (3.9) | 13 (4.2) | 0.76 |
| Constipation | 4 (2.6) | 5 (3.2) | 9 (2.9) | 0.74 |
| Diarrhea | 2 (1.3) | 5 (3.2) | 7 (2.2) | 0.44 |
| Other reason | 8 (5.1) | 8 (5.1) | 16 (5.1) | 0.80 |
- Citation: Tamaki H, Noda T, Morita M, Omura A, Kubo A, Ogawa C, Matsunaka T, Shibatoge M. Efficacy of 1.2 L polyethylene glycol plus ascorbic acid for bowel preparations. World J Clin Cases 2019; 7(4): 452-465
- URL: https://www.wjgnet.com/2307-8960/full/v7/i4/452.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v7.i4.452